首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   493篇
  免费   23篇
  国内免费   51篇
耳鼻咽喉   1篇
儿科学   31篇
基础医学   44篇
口腔科学   11篇
临床医学   103篇
内科学   109篇
皮肤病学   18篇
神经病学   5篇
特种医学   100篇
外科学   26篇
综合类   23篇
预防医学   25篇
眼科学   11篇
药学   37篇
肿瘤学   23篇
  2023年   4篇
  2021年   4篇
  2020年   6篇
  2019年   7篇
  2018年   3篇
  2017年   8篇
  2016年   13篇
  2015年   9篇
  2014年   16篇
  2013年   16篇
  2012年   5篇
  2011年   11篇
  2010年   11篇
  2009年   9篇
  2008年   9篇
  2007年   38篇
  2006年   5篇
  2005年   8篇
  2004年   4篇
  2003年   6篇
  2002年   9篇
  2001年   12篇
  2000年   7篇
  1999年   11篇
  1998年   26篇
  1997年   29篇
  1996年   16篇
  1995年   23篇
  1994年   15篇
  1993年   19篇
  1992年   11篇
  1991年   14篇
  1990年   13篇
  1989年   19篇
  1988年   17篇
  1987年   12篇
  1986年   18篇
  1985年   17篇
  1984年   12篇
  1982年   7篇
  1981年   9篇
  1980年   6篇
  1979年   7篇
  1978年   3篇
  1977年   8篇
  1976年   10篇
  1975年   6篇
  1970年   3篇
  1966年   2篇
  1924年   4篇
排序方式: 共有567条查询结果,搜索用时 15 毫秒
81.
Splenectomy in myeloid metaplasia   总被引:3,自引:0,他引:3  
Silverstein  MN; ReMine  WH 《Blood》1979,53(3):515-518
Between 1960 and 1977, 50 patients with agnogenic myeloid metaplasia were splenectomized. Twenty-five of 26 patients with painful splenomegaly, 4 of 9 patients with refractory hemolytic anemia, 4 of 10 patients with refractory thrombocytopenia, and 4 of 4 patients with portal hypertension showed significant benefit from the procedure. There were five immediate postoperative deaths. Four of these deaths occurred early in our series of splectomies for myeloid metaplasia before 1970. Only one death has occurred in the last 21 patients operated on. Survival following splenectomy averaged 25.5 mo.  相似文献   
82.
83.
The administration of glucocorticoids has been reported to exacerbate proteinuria in a few patients with glomerulonephritis. This effect has not been well recognized, and the pathogenetic mechanism responsible for this phenomenon remains to be clarified. In this study, we observed that a high daily oral dose (0.5 mg/kg body weight) of dexamethasone was capable of inducing overt proteinuria in mice, beginning on day 5 and persisting for a 19-day duration. One fourth of mice also intermittently presented with slight hematuria beginning on day 12. Renal lesions in the dexamethasone-treated mice, which were killed on day 23, were characterized by mild mesangial expansion, segmental or global hyalinosis/sclerosis in deep cortical glomeruli, and focal tubular changes. No glomerular inflammatory cell infiltration or proliferative lesion was noted in any of the mice. Ultrastructural features of glomeruli included mesangial widening characterized by either an increase of mesangial matrix, dilated mesangial channels filled with slightly electron-dense material or mesangial lysis-like appearance showing intracytoplasmic microcysts filled with electron-lucent material, and evidence to support injury of endothelial cells, erythrocytes, and podocytes. An immunofluorescence study revealed enhanced glomerular deposition of IgG, IgA, IgM, and fibrinogen (P < 0.001, compared with normal control mice), but no glomerular C3 deposition was identified in any of the dexamethasone-treated mice. Charge analysis showed no impairment in anionic property of glomerular tufts in the dexamethasone-treated mice. In addition, the dexamethasone-induced proteinuria was greatly attenuated by treatment with a low molecular weight heparin, although it was not reduced by an angiotensin-converting enzyme inhibitor. Data from these experiments suggest that a large dose of glucocorticoids is potentially nephrotoxic. Alteration of a size-dependent permeability may predominantly contribute to the dexamethasone-induced proteinuria. However, the effect of glomerular hyperfiltration may be only partially involved in the pathogenesis of this dexamethasone-induced glomerulopathy in mice.  相似文献   
84.
去甲乌药碱对实验性心力衰竭的治疗作用   总被引:11,自引:0,他引:11  
去甲乌药碱(DMC)是中药附子的有效成分之一。静脉滴注DMC2μg/kg/min共5min,使豚鼠正常心脏的收缩力明显加强,LVSP和LV dP/dtmax分别增加58±7和25±7%;心衰后,LVSP和LV dP/dtmax分别下降到心衰前的40±5和30.5±2.8%。DMC可使之恢复到79±14和75±9.9%,DMC也能加强离体豚鼠衰竭心脏的收缩力。DMC的强心作用与ISO相似,但前者作用较弱,作用维持时间较长,这可能与他们的作用机制不同有关。  相似文献   
85.
86.
myo‐Inositol (MI) plays an essential role in several important processes of cell physiology, is involved in the neural system, and provides an effective treatment for some psychiatric disorders. Its role in osteogenesis and bone formation nonetheless is unclear. Sodium/MI cotransporter 1 (SMIT1, the major cotransporter of MI) knockout (SMIT1?/?) mice with markedly reduced tissue MI levels were used to characterize the essential roles of MI and SMIT1 in osteogenesis. SMIT1?/? embryos had a dramatic delay in prenatal mineralization and died soon after birth owing to respiratory failure, but this could be rescued by maternal MI supplementation. The rescued SMIT1?/? mice had shorter limbs, decreased bone density, and abnormal bone architecture in adulthood. Deletion of SMIT1 resulted in retarded postnatal osteoblastic differentiation and bone formation in vivo and in vitro. Continuous MI supplementation partially restored the abnormal bone phenotypes in adult SMIT1?/? mice and strengthened bone structure in SMIT1+/+ mice. Although MI content was much lower in SMIT1?/? mesenchymal cells (MSCs), the I(1,4,5)P3 signaling pathway was excluded as the means by which SMIT1 and MI affected osteogenesis. PCR expression array revealed Fgf4, leptin, Sele, Selp, and Nos2 as novel target genes of SMIT1 and MI. SMIT1 was constitutively expressed in multipotential C3H10T1/2 and preosteoblastic MC3T3‐E1 cells and could be upregulated during bone morphogenetic protein 2 (BMP‐2)–induced osteogenesis. Collectively, this study demonstrated that deficiency in SMIT1 and MI has a detrimental impact on prenatal skeletal development and postnatal bone remodeling and confirmed their essential roles in osteogenesis, bone formation, and bone mineral density (BMD) determination. © 2011 American Society for Bone and Mineral Research.  相似文献   
87.
STUDY DESIGN: Observational, cohort study. OBJECTIVES: To test the hypothesis that patellar alignment and tibiofemoral rotation alignment explain unique portions of variance in patellofemoral joint contact area in individuals with patellofemoral pain (PFP) and in pain-free control subjects. BACKGROUND: PFP has been proposed to result from increased patellofemoral joint stress due to decreased contact area. Patellar malalignment (lateral displacement and tilt) is believed to be the main contributor to decreased contact area. Recent studies suggest that transverse plane rotation of the femur and/or tibia may also contribute to decreased contact area. METHODS AND MEASURES: Twenty-one subjects with PFP (16 female, 5 male) and 21 pain-free subjects (14 female, 7 male) participated. Subjects underwent magnetic resonance imaging with the knee in full extension and the quadriceps contracted. Measures of patellofemoral joint contact area, lateral patellar displacement, patellar tilt angle, tibiofemoral rotation angle, and patellar width were obtained. Hierarchical multiple regression analyses were performed for each group using contact area as the dependent variable. The order of independent variables was patellar width, patellar tilt angle, and tibiofemoral rotation angle. To avoid multicolinearity, lateral patellar displacement was not included. RESULTS: In the PFP group, patellar width and tibiofemoral rotation angle explained 46% of the variance in contact area. In pain-free subjects, patellar width was the only predictor of contact area, explaining 31% of its variance. Patellar tilt angle did not predict contact area in either group. CONCLUSION: Addressing factors that control tibiofemoral rotation may be indicated to increase contact area and reduce pain in individuals with PFP. Future studies should investigate the contributions of patellar alignment and tibiofemoral rotation to patellofemoral joint contact area at a variety of knee flexion angles.  相似文献   
88.
89.

Background

Mounting evidence shows that multi-intervention programmes for hypertension treatment are more effective than an isolated pharmacological strategy. Full economic evaluations of hypertension management programmes are scarce and contain methodological limitations. The aim of the study was to evaluate if a hypertension management programme for elderly patients is cost-effective compared to usual care from the perspective of a third-party payer.

Methods

We built a cost-effectiveness model using published evidence of effectiveness of a comprehensive hypertension programme vs. usual care for patients 65 years or older at a community hospital in Buenos Aires, Argentina. We explored incremental cost-effectiveness between groups. The model used a life-time framework adopting a third-party payer's perspective. Incremental cost-effectiveness ratio (ICER) was calculated in International Dollars per life-year gained. We performed a probabilistic sensitivity analysis (PSA) to explore variable uncertainty.

Results

The ICER for the base-case of the "Hypertension Programme" versus the "Usual care" approach was 1,124 International Dollars per life-year gained. PSA did not significantly influence results. The programme had a probability of 43% of being dominant (more effective and less costly) and, overall, 95% chance of being cost-effective.

Discussion

Results showed that "Hypertension Programme" had high probabilities of being cost-effective under a wide range of scenarios. This is the first sound cost-effectiveness study to assess a comprehensive hypertension programme versus usual care. This study measures hard outcomes and explores robustness through a probabilistic sensitivity analysis.

Conclusions

The comprehensive hypertension programme had high probabilities of being cost-effective versus usual care. This study supports the idea that similar programmes could be the preferred strategy in countries and within health care systems where hypertension treatment for elderly patients is a standard practice.  相似文献   
90.
Background Heart failure (HF) is a physically and socially debilitating disease that carries the burden of hospital re-admission and mortality. As an aging society, Hong Kong urgently needs to find ways to reduce the hospital readmission of HF patients. This study evaluates the effects of a nurse-led HF clinic on the hospital readmission and mortality rates among older HF patients in Hong Kong. Methods This study is a retrospective data analysis that compares HF patient in a nurse-led HF clinic in Hong Kong compared with HF patients who did not attend the clinic. The nurses of this clinic provide education on lifestyle modification and symptom monitoring, as well as titrate the medications and measure biochemical markers by following established protocols. This analysis used the socio-demographic and clinical data of HF patients who were aged ≥ 65 years old and stayed in the clinic over a six-month period. Results The data of a total of 78 HF patients were included in this data analysis. The mean age of the patients was 77.38 ± 6.80 years. Approximately half of the HF patients were male (51.3%), almost half were smokers (46.2%), and the majority received ≤ six years of formal education. Most of the HF patients (87.2%) belonged to classes II and III of the New York Heart Association Functional Classification, with a mean ejection fraction of 47.15 ± 20.31 mL. The HF patients who attended the clinic (n = 38, 75.13 ± 5.89 yrs) were significantly younger than those who did not attend the clinic (n = 40, 79.53 ± 6.96 yrs) (P = 0.04), and had lower recorded blood pressure. No other statistically significant difference existed between the socio-demographic and clinical characteristics of the two groups. The HF patients who did not attend the nurse-led HF clinic demonstrated a significantly higher risk of hospital readmission [odd ratio (OR): 7.40; P < 0.01] than those who attended after adjusting for the effect of age and blood pressure. In addition, HF patients who attended the clinic had lower mortality (n = 4) than those who did not attend (n = 14). However, such a difference did not reach statistical significance when the effects of age and blood pressure were adjusted. A significant reduction in systolic blood pressure [F (2, 94) = 3.39, P = 0.04] and diastolic blood pressure [F (2, 94) = 8.48, P < 0.01] was observed among the HF patients who attended the clinic during the six-month period. Conclusions The finding of this study suggests the important role of nurse-led HF clinics in reducing healthcare burden and improving patient outcomes among HF patients in Hong Kong.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号